Negative Regulation of Pancreatic and Duodenal Homeobox-1 by Somatostatin Receptor Subtype 5

被引:17
作者
Zhou, Guisheng [1 ,6 ]
Liu, Shi-He [1 ,6 ]
Shahi, Kelly M. [6 ]
Wang, Hua [4 ]
Duan, Xueyan [6 ]
Lin, Xia [6 ]
Feng, Xin-Hua [6 ]
Li, Min [3 ]
Fisher, William E. [6 ]
DeMayo, Francesco J. [5 ]
Dawson, David [2 ]
Brunicardi, F. Charles [1 ,6 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[3] Univ Texas Houston, Sch Med, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
GLUCAGON-LIKE PEPTIDE-1; INSULIN GENE-TRANSCRIPTION; PROLIFERATION IN-VITRO; DNA-BINDING ACTIVITY; NEUROENDOCRINE TUMORS; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL; 3-KINASE; CELL-DIFFERENTIATION; ENDOCRINE PANCREAS; PDX-1; EXPRESSION;
D O I
10.1210/me.2012-1095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Somatostatin receptor subtype 5 (SSTR5) mediates the inhibitory effect of somatostatin and its analogs on insulin expression/secretion and islet cell proliferation. We provide biochemical and genetic evidence that SSTR5 exerted its physiological actions via down-regulating pancreatic and duodenal homeobox-1 (PDX-1), a beta-cell-specific homeodomain-containing transcription factor. Cotransfection of SSTR5 with PDX-1 resulted in dose-dependent inhibition of PDX-1 expression in human embryonic kidney 293 cells. SSTR5 agonist RPL-1980 inhibited PDX-1 expression and abolished glucagon-like peptide 1-stimulated PDX-1 expression in mouse insulinoma beta-TC-6 cells. SSTR5 knockdown by short hairpin RNA led to increased PDX-1 expression that was accompanied by enhanced insulin secretion stimulated by high glucose in beta-TC6 cells and alternated expressions of cell cycle proteins that favor cell proliferation in mouse insulinoma MIN6 cells. Quantitative RT-PCR analysis showed that cotransfected SSTR5 inhibited PDX-1 mRNA expression, whereas knockdown of SSTR5 increased PDX-1 mRNA expression. In addition, we found that cotransfected wild-type SSTR5 increased PDX-1 ubiquitination in human embryonic kidney 293 cells, whereas SSTR5 P335L, a hypofunctional single nucleotide polymorphism of SSTR5, inhibited PDX-1 ubiquitination. SSTR5 knockout resulted in increased expression of PDX-1, insulin, and proliferating cell nuclear antigen in the islets of sstr(-/-) mice. Immunohistochemistry analysis showed that SSTR5 P335L was associated with elevated expression of PDX-1 in human pancreatic neuroendocrine tumor. Taken together, our studies demonstrated that SSTR5 is a negative regulator for PDX-1 expression and that SSTR5 may mediate the inhibitory effects of somatostatin and its analogs on insulin expression/secretion and cell proliferation via down-regulating PDX-1 at both transcriptional and posttranslational levels. (Molecular Endocrinology 26: 1225-1234, 2012)
引用
收藏
页码:1225 / 1234
页数:10
相关论文
共 72 条
  • [1] β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes
    Ahlgren, U
    Jonsson, J
    Jonsson, L
    Simu, K
    Edlund, H
    [J]. GENES & DEVELOPMENT, 1998, 12 (12) : 1763 - 1768
  • [2] Al-Quobaili F, 2008, INT J MOL MED, V21, P399
  • [3] PDX-1 and the pancreas
    Ashizawa, S
    Brunicardi, FC
    Wang, XP
    [J]. PANCREAS, 2004, 28 (02) : 109 - 120
  • [4] Peptide receptor therapies in neuroendocrine tumors
    Bodei, L.
    Ferone, D.
    Grana, C. M.
    Cremonesi, M.
    Signore, A.
    Dierckx, R. A.
    Paganelli, G.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (04): : 360 - 369
  • [5] Phosphorylation marks IPF1/PDX1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms
    Boucher, MJ
    Selander, L
    Carlsson, L
    Edlund, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) : 6395 - 6403
  • [6] Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion
    Brissova, M
    Shiota, M
    Nicholson, WE
    Gannon, M
    Knobel, SM
    Piston, DW
    Wright, CVE
    Powers, AC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) : 11225 - 11232
  • [7] Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells
    Buteau, J
    Roduit, R
    Susini, S
    Prentki, M
    [J]. DIABETOLOGIA, 1999, 42 (07) : 856 - 864
  • [8] Somatostatin and somatostatin receptors: from basic concepts to clinical applications
    De Martino, Maria Cristina
    Hofland, Leo J.
    Lamberts, Steven W. J.
    [J]. NEUROENDOCRINOLOGY: PATHOLOGICAL SITUATIONS AND DISEASES, 2010, 182 : 255 - 280
  • [9] Fagan SP, 1998, SURGERY, V124, P254, DOI 10.1016/S0039-6060(98)70128-X
  • [10] PDX-1 expression is associated with islet proliferation in vitro and in vivo
    Feanny, Mark A.
    Fagan, Shawn P.
    Ballian, Nikiforos
    Liu, Shi-He
    Li, Zhijun
    Wang, Xiaoping
    Fisher, William
    Brunicardi, Charles
    Belaguli, Narasimhaswamy S.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2008, 144 (01) : 8 - 16